Marin Nola

538 total citations
31 papers, 405 citations indexed

About

Marin Nola is a scholar working on Pathology and Forensic Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Marin Nola has authored 31 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 8 papers in Obstetrics and Gynecology and 7 papers in Oncology. Recurrent topics in Marin Nola's work include Lymphoma Diagnosis and Treatment (10 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Marin Nola is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Marin Nola collaborates with scholars based in Croatia, United States and Austria. Marin Nola's co-authors include Diana N. Ionescu, Sanja Đačić, Kathleen Cieply, Snježana Dotlić, Mladen Petrovečki, Matko Marušić, Boris Labar, Branka Užarević, Igor Aurer and Nenad Veček and has published in prestigious journals such as Cancer, Gynecologic Oncology and American Journal of Hematology.

In The Last Decade

Marin Nola

31 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marin Nola Croatia 11 129 120 106 89 76 31 405
Robyn Cheuk Australia 9 37 0.3× 74 0.6× 145 1.4× 30 0.3× 104 1.4× 26 322
Yoji Wani Japan 12 66 0.5× 83 0.7× 100 0.9× 19 0.2× 83 1.1× 34 323
Shigeo Nakamura Japan 9 249 1.9× 215 1.8× 41 0.4× 88 1.0× 22 0.3× 12 437
Pimkhuan Kamnerdsupaphon Thailand 11 97 0.8× 134 1.1× 92 0.9× 70 0.8× 36 0.5× 28 565
Mette Winderen Lindegaard Norway 8 54 0.4× 109 0.9× 42 0.4× 21 0.2× 87 1.1× 16 419
H Hagberg Sweden 9 83 0.6× 101 0.8× 24 0.2× 20 0.2× 112 1.5× 14 310
T.B. Johannesen Norway 11 36 0.3× 142 1.2× 41 0.4× 29 0.3× 98 1.3× 17 472
Priti Trivedi India 10 96 0.7× 74 0.6× 15 0.1× 79 0.9× 33 0.4× 79 340
Jim Biagi Canada 10 106 0.8× 158 1.3× 252 2.4× 28 0.3× 275 3.6× 17 648
André Pinto United States 16 116 0.9× 270 2.3× 158 1.5× 45 0.5× 119 1.6× 56 753

Countries citing papers authored by Marin Nola

Since Specialization
Citations

This map shows the geographic impact of Marin Nola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marin Nola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marin Nola more than expected).

Fields of papers citing papers by Marin Nola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marin Nola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marin Nola. The network helps show where Marin Nola may publish in the future.

Co-authorship network of co-authors of Marin Nola

This figure shows the co-authorship network connecting the top 25 collaborators of Marin Nola. A scholar is included among the top collaborators of Marin Nola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marin Nola. Marin Nola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nola, Marin, et al.. (2009). Giant basal cell carcinoma of the back: a case report and review of the literature.. PubMed. 33(1). 315–8. 8 indexed citations
2.
Mitrović, Zdravko, Ivana Ilić, Marin Nola, et al.. (2009). CD43 Expression Is an Adverse Prognostic Factor in Diffuse Large B-Cell Lymphoma. Clinical Lymphoma & Myeloma. 9(2). 133–137. 19 indexed citations
3.
Ilić, Ivana, Zdravko Mitrović, Igor Aurer, et al.. (2009). Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab. International Journal of Hematology. 90(1). 74–80. 24 indexed citations
4.
Mitrović, Zdravko, et al.. (2009). CD13+ anaplastic large cell lymphoma with leukemic presentation and additional chromosomal abnormality. Diagnostic Cytopathology. 38(2). 141–146. 4 indexed citations
5.
Brčić, Iva, Boris Labar, Melita Perić Balja, Sandra Bašić‐Kinda, & Marin Nola. (2008). Terminal deoxynucleotidyl transferase negative T-cell lymphoblastic lymphoma in aleukemic patient. International Journal of Hematology. 88(2). 189–191. 6 indexed citations
6.
Mršić, Mirando & Marin Nola. (2008). Rare Diseases in Croatia – Lesson Learned from Anderson-Fabry Disease. Croatian Medical Journal. 49(5). 579–581. 3 indexed citations
7.
Aurer, Igor, Zdravko Mitrović, Dan Nemet, et al.. (2008). Treatment of Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma with Two Ifosfamide-Based Regimens, IMVP and ICE. Journal of Chemotherapy. 20(5). 640–644. 3 indexed citations
8.
Korać, Petra, et al.. (2008). Prognostic Significance of B-cell Differentiation Genes Encoding Proteins in Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3. Croatian Medical Journal. 49(5). 625–635. 4 indexed citations
9.
Anić, Branimir, et al.. (2007). [Leukocytoclastic vasculitis in primary Sjögren syndrome: a case report].. PubMed. 129(5). 134–7. 1 indexed citations
11.
Ionescu, Diana N., et al.. (2005). Protein expression and gene amplification of epidermal growth factor receptor in thymomas. Cancer. 103(3). 630–636. 61 indexed citations
12.
Nola, Marin, Steven Z. Pavletic, Dennis D. Weisenburger, et al.. (2004). Prognostic factors influencing survival in patients with B‐cell small lymphocytic lymphoma. American Journal of Hematology. 77(1). 31–35. 8 indexed citations
13.
Hudolin, Tvrtko, et al.. (2004). Ureteral metastasis of occult breast cancer. The Breast. 13(6). 530–532. 12 indexed citations
14.
Borčić, Josipa, et al.. (2004). Primary non-Hodgkin’s lymphoma of the oral cavity. 41(1). 12–14. 29 indexed citations
15.
Dominis, Mara, et al.. (1999). Computer-based teaching of pathology at the Zagreb University School of Medicine.. PubMed. 40(3). 425–8. 5 indexed citations
16.
Nola, Marin, Branka Užarević, Mladen Petrovečki, et al.. (1999). Effects of Tamoxifen on Steroid Hormone Receptors and Hormone Concentration and the Results of DNA Analysis by Flow Cytometry in Endometrial Carcinoma. Gynecologic Oncology. 72(3). 331–336. 11 indexed citations
17.
Nola, Marin, et al.. (1996). Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus. Cancer. 78(12). 2543–2550. 46 indexed citations
18.
Nola, Marin, Matko Marušić, Jessica G.Y. Luc, et al.. (1994). Prognostic value of steroid hormone receptors concentration in patients with endometrial Carcinoma. Acta Obstetricia Et Gynecologica Scandinavica. 73(9). 730–733. 17 indexed citations
19.
Veček, Nenad, Marin Nola, Matko Marušić, et al.. (1994). Tumor Cell Cycle in Patients with Stage I Endometrial Carcinoma. Gynecologic Oncology. 53(1). 38–43. 8 indexed citations
20.
Veček, Nenad, et al.. (1993). Prognostic impact of peritoneal cytology in patients with endometrial carcinoma.. PubMed. 14(5). 380–5. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026